CLEC2A and xeroderma pigmentosum: Recently, Magnaldo and colleagues described an antitumoral involvement of the NKp65-KACL axis, namely the restriction of squamous cell carcinoma invasion in Xeroderma pigmentosum patients [7] which led to the notification of the KLRF2 gene in the DISGENET database [21].